BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23098081)

  • 1. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ; Au DH; Fitzgibbon ML; Lee TA
    Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.
    Eurich DT; Lee C; Marrie TJ; Majumdar SR
    Clin Infect Dis; 2013 Oct; 57(8):1138-44. PubMed ID: 23872948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S; Plauschinat CA; Wu N; Fraser K; Boulanger L
    J Med Econ; 2011; 14(4):458-62. PubMed ID: 21651427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA; Weiss KB
    Am J Respir Crit Care Med; 2004 Apr; 169(7):855-9. PubMed ID: 14711795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA; Fabbri LM; Davis KJ; Soriano JB
    Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of inhaled corticosteroids and the risk of tuberculosis.
    Lee CH; Kim K; Hyun MK; Jang EJ; Lee NR; Yim JJ
    Thorax; 2013 Dec; 68(12):1105-13. PubMed ID: 23749841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD.
    Huiart L; Ernst P; Ranouil X; Suissa S
    Eur Respir J; 2005 Apr; 25(4):634-9. PubMed ID: 15802336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C; Nielsen R; Thomsen VØ; Duhaut P; Sørensen HT; Thomsen RW
    Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P; Gonzalez AV; Brassard P; Suissa S
    Am J Respir Crit Care Med; 2007 Jul; 176(2):162-6. PubMed ID: 17400730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
    Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
    BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia.
    Singanayagam A; Chalmers JD; Akram AR; Hill AT
    Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
    Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis.
    Flynn RW; MacDonald TM; Hapca A; MacKenzie IS; Schembri S
    Respir Res; 2014 Nov; 15(1):141. PubMed ID: 25407604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)-The OUTPUL Study.
    Cascini S; Kirchmayer U; Belleudi V; Bauleo L; Pistelli R; Di Martino M; Formoso G; Davoli M; Agabiti N
    COPD; 2017 Jun; 14(3):311-317. PubMed ID: 28406337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB; Rigby A; Morice AH
    Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
    Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.